NF-κB activation in inflammatory cells controls the production of pro-inflammatory cytokines, including TNFα, IL-1, IL-6, and IL-23, which mediate tumor promotion and progression, as well as NF-κB activation in tumor cells [8], [11]. The gene discussed is TNF; the disease is neoplasm.